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The expression of the divergently transcribed paaZ
and paaABCDEFGHIJK catabolic operons, which are
responsible for phenylacetic acid (PA) degradation in
Escherichia coli, is driven by the Pz and Pa promoters,
respectively. To study the transcriptional regulation of
the inducible paa catabolic genes, genetic and biochem-
ical approaches were used. Gel retardation assays show-
ing that the PaaX regulator binds specifically to the Pa
and Pz promoters were complemented with in vivo ex-
periments that indicated a PaaX-mediated repression
effect on the expression of Pa-lacZ and Pz-lacZ reporter
fusions. The region within the Pa and Pz promoters that
is protected by the PaaX repressor in DNase I footprint-
ing assays contains a conserved 15-base pair imperfect
palindromic sequence motif that was shown, through
mutational analysis, to be indispensable for PaaX bind-
ing and repression. PA-coenzyme A (PA-CoA), but not
PA, specifically inhibited binding of PaaX to the target
sequences, thus confirming the first intermediate of the
pathway as the true inducer and PaaX as the only bac-
terial regulatory protein described so far that responds
to an aryl-CoA compound. Superimposed in the specific
PaaX-mediated regulation is transcriptional activation
by the cAMP receptor protein and the integration host
factor protein. These global regulators may adjust the
transcriptional output from Pa and Pz promoters to the
overall growth status of the cell.
Phenylacetic acid (PA)1 is a central compound to which pol-
lutants, such as styrene and trans-styrylacetic acid, as well as
other aromatic compounds, such as 2-phenylethylamine, phen-
ylacetaldehyde, and several phenylalkanoic acids with an even
number of carbon atoms, converge through different peripheral
catabolic pathways (1, 2). Aerobic PA catabolism in Pseudomo-
nas putida U and Escherichia coli W has been reported to
represent a novel aerobic hybrid pathway whose first step is
the activation of PA to phenylacetyl-coenzyme A (PA-CoA) by
the action of a PA-CoA ligase (1, 2). In E. coli K-12 and E. coli
W, the paa genes responsible for PA catabolism are clustered in
the chromosome at min 31.0 according to the E. coli K-12
linkage map (2). The 14 paa genes are organized in three
transcription units as follows: two divergently transcribed
operons, paaZ and paaABCDEFGHIJK, encoding the catabolic
genes and whose expression is driven by the Pz and Pa pro-
moters, respectively, and the paaXY operon expressing the
paaX regulatory gene from the Px promoter (2). The absence of
the paa genes in E. coli W14, an E. coli W mutant strain (3),
leads to a PA2 phenotype (2).
Previous work involving Pa-lacZ translational fusions re-
vealed that the Pa promoter is negatively regulated by the
paaX gene product since the absence of the latter caused a
constitutive expression of the reporter fusion (2). The PaaX
repressor is a 316-amino acid protein that shows 41.4% amino
acid sequence identity with its ortholog PhaN (recently re-
named as PaaN (4)) from the PA degradation pathway of P.
putida U (1) and contains a stretch of 25 residues at amino
acids 39–64 that shares similarity with the helix-turn-helix
motif for DNA recognition and binding of transcriptional re-
pressors from the GntR family such as FadR (5) and GntR (6).
It is worth mentioning that whereas activator proteins are very
common in transcriptional regulation of aromatic catabolic
operons, only a few repressors have been described so far in
biodegradation of aromatic compounds, namely HpaR (HpcR)
for the catabolism of homoprotocatechuic acid in E. coli (7, 8),
CymR for the catabolism of p-cymene in P. putida F1 (9), and
AphS for the catabolism of phenol in Comamonas testosteroni
TA441 (10).
The repressor effect of PaaX on the Pa promoter in E. coli
W14(lacZ2) cells, containing the Pa-lacZ fusion into the chro-
mosome and the paaX gene in a plasmid, could not be allevi-
ated by growing the cells in the presence of PA, suggesting that
this aromatic compound is not the inducer of the pathway (2).
However, the simultaneous expression of genes paaX and
paaK, the latter encoding the PA-CoA ligase that catalyzes the
activation of PA to PA-CoA, allowed activity of the Pa promoter
when the cells were grown in the presence of PA, suggesting
that PA-CoA rather than PA is the true inducer of the
pathway (2).
Due to the unusual catabolic and regulatory features mentioned
above, the PA biodegradation pathway becomes a very interesting
model of an aerobic hybrid route for the catabolism of aromatic
compounds. In this work, we have performed both in vivo and in
vitro experiments to investigate the regulation of gene expression of
the paaZ and paaABCDEFGHIJK catabolic operons from E. coli.
Superimposed in the specific PaaX-mediated repression, two global
regulators, the cAMP receptor protein (CRP) and the integration
host factor protein (IHF), act as activators of the gene expression
driven by Pa and Pz promoters.
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EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions—The E. coli
strains and plasmids used in this work are listed in Table I. The E. coli
AF15 strain was obtained by transferring the (argF-lac)U169 deletion
of E. coli SH210 to E. coli W14Rif through biparental mating (12) and
selecting for a clone resistant to tetracycline and rifampicin. Unless
otherwise stated, bacteria were grown in Luria-Bertani (LB) medium
(11) at 37 °C. Growth in M63 minimal medium (16) was achieved at
30 °C using the corresponding necessary nutritional supplements and
20 mM glycerol or 10 mM glucose as carbon source. When required, 1 mM
PA was added to the M63 minimal medium. Where appropriate, anti-
biotics were added at the following concentrations: ampicillin (100
mg/ml), chloramphenicol (35 mg/ml), tetracycline (10 mg/ml), kanamycin
(50 mg/ml), and rifampicin (50 mg/ml).
DNA Manipulations and Sequencing—Plasmid DNA was prepared
by the rapid alkaline lysis method (11). Transformation of E. coli was
carried out using the RbCl method (11). DNA manipulations and other
molecular biology techniques were essentially as described (11). DNA
fragments were purified using the Geneclean Kit (Bio 101, Inc.). Oligo-
nucleotides were synthesized on an Oligo-1000M nucleotide synthesizer
(Beckman Instruments). Nucleotide sequences were determined di-
rectly from plasmids by using the dideoxy chain termination method
(17). Standard protocols of the manufacturer for Taq DNA polymerase-
initiated cycle sequencing reactions with fluorescently labeled
dideoxynucleotide terminators (Applied Biosystems Inc.) were used.
The sequencing reactions were analyzed using a model 377 automated
DNA sequencer (Applied Biosystems Inc.).
Mutagenesis of the PaaX Binding Motif—Base substitutions in the
PaaX binding motif were introduced through recombinant PCR using
the plasmid pAAD as template. To generate mutations in the left-half
site of the PaaX binding motif, a first PCR reaction was performed using
two pairs of primers as follows: PA5–1 (59-CAATCTCGGAATGCG-
CATG-39, which encodes amino acids 38–44 of PaaA and hybridizes
with the non-coding strand of the paaA gene between nucleotides 2885
and 2867 of the paa gene cluster (2), underlined are the bases that
reconstruct a BbuI restriction site) and the degenerated MUT-PA5
(59-CTTTCATAAAACAATGWKMTTCGTGTTTTTAATT-39, which hy-
bridizes between nucleotides 2688 and 2721 enclosing the transcription
start sites of Pa (2), see also Fig. 4, where K is G or T, M is A or C, and
W is A or T); and PAP (59-GGTCTAGAGTTATCAAAATAGAGTGCG-39,
located between the Pz and Pa promoters, nucleotides 2611–2631 of the
paa gene cluster (2) (see Fig. 4), where the engineered XbaI site is
underlined) and the degenerated MUT-PA3 (59-AATTAAAAACAC-
GAAKMWCATTGTTTTATGAAAG-39, which is complementary to the
MUT-PA5 oligonucleotide). The resulting two PCR products were mixed
and subjected to a further PCR reaction using PAP and PA5–1 as
TABLE I
Bacteria and plasmids used in this study
Strain or plasmid Relevant genotype and characteristic(s) Ref. or origin
E. coli K-12
DH5a endA1 hsdR17 supE44 thi-1 recA1 gyrA(Nalr) relA1 D(argF-lac)U169 deoR f80dlacD(lacZ)M15 11
S17–1lpir Tpr Smr recA thi hsdR2M1 RP4::2-Tc::Mu::Km Tn7 lpir phage lysogen 12
CC118lpir D(ara-leu) araD DlacX74 galE galK phoA thi-1 rpsE (Spr) rpoB(Rifr) argE(am) recA1 lpir phage lysogen 12
S90C D(lac, pro) rpsL (Smr) 13
DPB101 S90C himD451::mini-tet 13
DPB102 S90C himA452::mini-tet 13
MC4100 araD319 D(argF-lac)U169 rpsL150 (Smr) relA1flbB5301 deoC1 ptsF25 rbsR 14
SBS688 MC4100 Dcrp 14
SH210 Hfr (PO2A), D(argF-lac)169, zai-736::Tn10(Tcr) 15
AFMC MC4100 spontaneous rifampicin-resistant mutant (Rifr) This work
AFSB SBS688 spontaneous rifampicin-resistant mutant (Rifr) This work
S90CRif S90C spontaneous rifampicin-resistant mutant (Rifr) This work
DPB101Rif DPB101 spontaneous rifampicin-resistant mutant (Rifr) This work
DPB102Rif DPB102 spontaneous rifampicin-resistant mutant (Rifr) This work
S90CPA S90CRif with chromosomal insertion mini-Tn5Km2 Pa-lacZ This work
S90CPZ S90CRif with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
DPB101PA DPB101Rif with chromosomal insertion mini-Tn5Km2 Pa-lacZ This work
DPB101PZ DPB101Rif with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
DPB102PA DPB102Rif with chromosomal insertion mini-Tn5Km2 Pa-lacZ This work
DPB102PZ DPB102Rif with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
AFMCPA AFMC with chromosomal insertion mini-Tn5Km2 Pa-lacZ This work
AFMCPZ AFMC with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
AFSBPA AFSB with chromosomal insertion mini-Tn5Km2 Pa-lacZ This work
AFSBPZ AFSB with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
E. coli W
W14 W Dpaa 3
W14Rif W14 spontaneous rifampicin-resistant mutant (Rif r) 2
AF15 W14Rif Dlac This work
AF15PZ AF15 with chromosomal insertion mini-Tn5Km2 Pz-lacZ This work
Plasmids
pUTmini-Tn5Km2 Apr Kmr; R6KoriV RP4oriT, mini-Tn5 Km2 transposon delivery plasmid 12
pSJ3 Aprr; 9lacZ promoter probe vector, lacZ fusion flanked by NotI sites 2
pAFPZ Apr; pSJ3 containing a 446-bp BbuI-BamHI DNA fragment to produce the Pz-lacZ fusion 2
pAFPZT Apr Kmr; pUTmini-Tn5 Km2 containing the 4.4-kba NotI Pz-lacZ fragment from pAFPZ This work
pAFPA1T Apr Kmr; pUTmini-Tn5 Km2 containing the 4.4-kb NotI Pa-lacZ fragment 2
pCK01 Cmr; low copy number cloning vector (pSC101 derivative), polylinker flanked by NotI sites 2
pAAD Cmr; pCK01 containing a 15.5-kb DNA fragment carrying the paa cluster 2
pAFK5 Apr; high copy number pUC19 derivative containing the paaK gene under Plac 2
pUC18 Apr; high copy number cloning vector 11
pAFX Apr; pUC18 expressing the paaX gene under Plac 2
pAFX2 Cmr; pCK01 expressing the paaX gene under Plac 2
pAFPA2 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the Pa-lacZ fusion 2
pAFPA2-M1 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM1-lacZ fusion This work
pAFPA2-M5 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM5-lacZ fusion This work
pAFPA2-M9 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM9-lacZ fusion This work
pAFPA2-M16 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM16-lacZ fusion This work
pAFPA2-M18 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM18-lacZ fusion This work
pAFPA2-M22 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM22-lacZ fusion This work
pAFPA2-M25 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM25-lacZ fusion This work
pAFPA2-M26 Apr; pSJ3 containing a 255-bp XbaI-BbuI DNA fragment to produce the PaM26-lacZ fusion This work
a kb, kilobase pair.
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primers. Similarly, to generate mutations in the right-half site of the
PaaX binding motif, a first PCR reaction was performed using two pairs
of primers: PA5–1 and the degenerated MUT-PA52 (59-CATAAAA-
CAATGTGATTCGWSWWTTTAATTAATTCACG-39, which hybridizes
between nucleotides 2692 and 2729 enclosing the transcription start
sites of Pa (2), see also Fig. 4; where S means C or G); and PAP and the
degenerated MUT-PA32 (59-CGTGAATTAATTAAAWWSWCGAATCA-
CATTGTTTTATG-39, which is complementary to the MUT-PA52 oligo-
nucleotide). The resulting two PCR products were mixed and subjected
to a further PCR reaction using PAP and PA5–1 as primers. The
amplified 272-bp fragments were digested with XbaI and BbuI and
cloned as 255-bp fragments into the double-digested XbaI1BbuI pSJ3
promoter probe vector, giving rise to the pAFPA2-M plasmids (Table I),
which were further sequenced to confirm the nucleotide sequence of the
cloned mutant fragments.
Construction of E. coli Strains Harboring Chromosomal Insertions of
the Pa-lacZ and Pz-lacZ Translational Fusions—By means of RP4-
mediated mobilization, plasmids pAFPA1T and pAFPZT, which contain
mini-Tn5Km2 hybrid transposons expressing Pa-lacZ and Pz-lacZ fu-
sions, respectively, were transferred from E. coli S17–1lpir into differ-
ent rifampicin-resistant E. coli recipient strains, i.e. AF15, S90CRif,
DPB101Rif, DPB102Rif, AFMC, and AFSB, as described previously
(12). Exconjugants containing the lacZ translational fusions stably
inserted into the chromosome were selected for the transposon marker,
kanamycin, on rifampicin-containing LB medium. The resulting
strains, AF15PZ, S90CPA, S90CPZ, DPB101PA, DPB101PZ,
DPB102PA, DPB102PZ, AFMCPA, AFMCPZ, AFSBPA, and AFSBPZ,
and their relevant genotype are indicated in Table I.
Production of the PaaX Repressor—The paaX gene was expressed
from the Plac promoter in the high copy number pAFX plasmid and in
the low copy number pAFX2 plasmid. SDS-polyacrylamide gel electro-
phoresis analyses of crude lysates from E. coli cells harboring plasmids
pAFX or pAFX2 did not show the presence of an intense band corre-
sponding to the PaaX protein when they were compared with crude
lysates from cells harboring the parental plasmids, thus indicating that
the paaX gene was not overexpressed in these recombinant plasmids.
To prepare crude extracts containing the PaaX protein, PaaX1 ex-
tracts, E. coli W14 (pAFX) cells were grown in ampicillin-containing LB
medium to an A600 of about 1. Cell cultures were then centrifuged
(3,000 3 g, 10 min at 20 °C), and cells were washed and resuspended in
0.05 volumes of 20 mM Tris-HCl buffer, pH 7.5, containing 10% glycerol,
2 mM b-mercaptoethanol, and 50 mM KCl, prior to disruption by passage
through a French press (Aminco Corp.) operated at a pressure of 20,000
pounds/square inch. The cell debris was removed by centrifugation at
26,000 3 g for 30 min at 4 °C. The clear supernatant fluid was decanted
and used as crude cell extract. The PaaX2 extracts from E. coli W14
(pUC18) cells were prepared in a similar manner. Protein concentration
was determined by the method of Bradford (18) using bovine serum
albumin as standard.
Synthesis of DNA Fragments Covering the paaZ-paaA Intergenic
Region—The target DNA fragments used as probes were generated by
PCR using plasmid pAAD as template. To prepare the Pz-Pa fragment
(483-bp), primers PZ5 (59-GGGGTGAATCAAACGGCTACG-39, which
encodes amino acids 18–23 of PaaZ and hybridizes with the non-coding
strand of the paaZ gene between nucleotides 2402 and 2420 of the paa
gene cluster (2)) and PA5–1 were used. To prepare the Pa fragment
(274-bp), primers PAP and PA5–1 were used. To prepare the Pz frag-
ment (242-bp), primers SG-1 (59-CTGTGACAGATTTCGCACTC-39,
which hybridizes between nucleotides 2644 and 2625 of the paaZ-paaA
intergenic region (2), see also Fig. 4) and PZ5 were used.
The 217-bp DNA fragments harboring mutations in the PaaX bind-
ing motif were PCR-amplified from the pAFPA2-M series of plasmids
(Table I) using primers PAP and PA5–4 (59-CGGGCATCCAGTCCTGT-
GGCTCG-39, which encodes amino acids 18–25 of PaaA and hybridizes
with the non-coding strand of the paaA gene between nucleotides 2828
and 2806 (2)). The PAP and PA5–4 primers were also used to amplify
the wild-type Pa promoter from the pAFPA2 plasmid.
Gel Retardation Assays—DNA fragments used as probes were la-
beled at their 59-end with phage T4 polynucleotide kinase (Amersham
Pharmacia Biotech) and [g-32P]ATP (Amersham Pharmacia Biotech).
The reaction mixtures contained 20 mM Tris-HCl, pH 7.5, 10% glycerol,
2 mM b-mercaptoethanol, 50 mM KCl, 0.1 nM DNA probe, 50 mg/ml
bovine serum albumin, 50 mg/ml salmon sperm (competitor) DNA, and
cell extract or purified IHF or CRP in a 20-ml final volume. Purified IHF
and CRP were kindly provided by S. Goodman and A. Kolb, respec-
tively. After incubation for 20 min at 30 °C, mixtures were fractionated
by electrophoresis in 4% polyacrylamide gels buffered with 0.53 TBE
(45 mM Tris borate, 1 mM EDTA). The gels were dried onto Whatman
3MM paper and exposed to Hyperfilm MP (Amersham Pharmacia Bio-
tech). For quantitative definition of the PaaX-DNA interactions, auto-
radiograms were scanned in a computing densitometer, and the inten-
sity of the bound and unbound DNA bands was measured using the
ImageQuant software (Molecular Dynamics). The apparent dissociation
constant (Kd(app)) of PaaX for the probe DNA was defined as the amount
of total protein per ml of reaction mixture at which half of the labeled
DNA remained unbound.
DNase I Footprinting Assays—DNA fragments to be used as probes
were singly 59-end-labeled by using a labeled primer during the PCR-
amplification reaction. The desired primer (50 pmol) was 59-end-labeled
with [g-32P]ATP using T4 polynucleotide kinase. Unincorporated nucle-
otides were removed in a G-25 Sephadex column (Amersham Pharma-
cia Biotech), and the labeled primer was eluted with 100 ml of water. To
perform the PCR reaction, 25 pmol of both the labeled and unlabeled
primers were used. The 59-end-labeled PCR product was separated in a
2% agarose gel and purified through the Geneclean DNA purification
kit (Bio 101). For DNase I footprinting assays, the reaction mixture
contained 20 mM Tris-HCl, pH 7.5, 10% glycerol, 2 mM b-mercaptoeth-
anol, 50 mM KCl, 0.1 nM DNA probe, 50 mg/ml bovine serum albumin, 50
mg/ml salmon sperm (competitor) DNA, and cell extract in a 100-ml final
volume. This mixture was incubated for 20 min at 30 °C, after which 2
ml (0.005 units) of DNase I (Sigma) (prepared at 1 ng/ml in 125 mM
CaCl2, 50 mM MgCl2) was added, and the incubation was continued for
2 min at 37 °C. After phenol/chloroform extraction, ammonium acetate
was added to the clear supernatant to a final concentration of 0.2 M, and
DNA fragments were precipitated with ethanol absolute, washed with
70% ethanol, and directly resuspended in 5 ml of 90% (v/v) formamide-
loading gel buffer (10 mM Tris-HCl, pH 8.0, 20 mM EDTA, pH 8.0, 0.05%
(w/v) bromphenol blue, 0.05% (w/v) xylene cyanol). Samples were then
denatured at 95 °C for 2 min and fractionated in a 8% polyacrylamide-
urea gel. A 1 G Maxam and Gilbert reactions (19) were carried out with
the same fragments and loaded in the gels along with the footprinting
samples. The gels were dried onto Whatman 3MM paper and exposed to
Hyperfilm MP (Amersham Pharmacia Biotech).
b-Galactosidase Assays—b-Galactosidase activities were measured
with permeabilized cells as described by Miller (16).
RESULTS
The PaaX Repressor Regulates the Pz Promoter—We have
previously shown that the Pa promoter, which drives the ex-
pression of the paaABCDEFGHIJK catabolic operon, is re-
pressed by the PaaX regulator (2). To check whether the ex-
pression of the divergently transcribed Pz promoter, which
drives the expression of the paaZ catabolic gene, was also
regulated by PaaX, we have engineered a reporter Pz-lacZ
fusion within a mini-Tn5 vector. The resulting construction,
pAFPZT, was used to deliver by transposition the Pz-lacZ
translational fusion into the chromosome of E. coli AF15, a Dlac
derivative of E. coli W14Rif (Dpaa), giving rise to the reporter
strain E. coli AF15PZ. The b-galactosidase assays of permeabi-
lized E. coli AF15PZ cells harboring control plasmid pUC19 or
the plasmid pAFK5, a pUC19 derivative that expresses the
paaK gene encoding the PA-CoA ligase, revealed a similar and
constitutive expression of the Pz-lacZ fusion (Table II). When
the paaX gene was expressed in trans from the pAFX2 plasmid
in E. coli AF15PZ cells grown in glycerol-containing minimal
medium in the presence or in the absence of 1 mM PA, no
b-galactosidase activity was detected (Table II). However,
when the paaX and paaK genes were simultaneously expressed
in the reporter strain, b-galactosidase activity was observed
when the cells were grown in the presence of 1 mM PA, and no
activity was detected in the absence of this aromatic compound
(Table II). These data, therefore, indicate that PaaX behaves as
a transcriptional repressor of Pz and suggest that the product
of the reaction catalyzed by PaaK, i.e. PA-CoA, is the true
inducer of this promoter.
Binding of PaaX to the Pa and Pz Promoter Regions—Cell-
free extracts from E. coli W14 (pAFX), a strain that expresses
the paaX gene under the Plac promoter, were subjected to gel
retardation analysis using as probe a 483-bp DNA fragment
carrying the Pz and Pa promoters (Pz-Pa probe). As shown in
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Fig. 1, whereas extracts containing PaaX were able to retard
the migration of the Pz-Pa probe in a protein concentration-de-
pendent manner, control extracts prepared from E. coli W14
(pUC18) cells, did not. Moreover, whereas a 6000-fold excess
amount of an unrelated DNA such as that of salmon sperm did
not affect the binding of PaaX to the target DNA, migration of
the labeled fragment was not retarded when a 10-fold excess
amount of non-labeled Pz-Pa fragment was added to the assay
(data not shown), indicating that binding of the PaaX repressor
to the Pz-Pa promoter region was specific. As the amount of
PaaX protein increased, two distinct complexes, complex 1
(higher mobility) and 2 (lower mobility), were observed (Fig. 1),
a result that might suggest that PaaX binds with different
affinities to two sites in the fragment used as probe. To confirm
the existence of two different PaaX-binding sites, gel retarda-
tion assays were performed using the 242-bp Pz fragment (from
position 2146 to 197 relative to the transcription start site of
Pz promoter) and the 274-bp Pa fragment (from position 287 to
1187 relative to the major transcription start site of Pa pro-
moter), as probes. As shown in Fig. 1, one shifted band was
found with each individual probe fragment. Since the deduced
Kd(app) of PaaX (see under “Experimental Procedures”) for the
Pa and Pz probes, 7 and 150 mg protein/ml, respectively, were
similar to that for complex 1 and complex 2 with the Pz-Pa
probe, there is no cooperativity in the binding of PaaX to the Pa
and Pz promoters. Therefore, these data taken together re-
vealed the specific and independent binding of PaaX to the Pz
and Pa promoters.
PA-CoA Specifically Inhibits Binding of PaaX to Its Cognate
Promoter Region—We have shown that the lacZ expression
driven by the Pa (2) and Pz (see above) promoters in cells
containing the paaX gene in a plasmid requires the simultane-
ous expression of the paaK gene encoding the PA-CoA ligase
activity, as well as the presence of PA in the culture medium.
This has led to the suggestion that the true inducer of the paa
catabolic cluster is PA-CoA rather than PA. Nevertheless, since
acyl-CoA ligases have been shown to play a role in the cellular
uptake of some substrates such as long chain fatty acids (20),
we could not exclude the possibility that E. coli cells lacking the
paaK gene could have some deficiency in PA uptake that would
lead to noninducible paa cluster expression. We therefore
tested by gel retardation assays the ability of PA and PA-CoA
to inhibit binding of PaaX to the Pa promoter region in vitro
(Fig. 2). Whereas 30 mM PA-CoA reduced the amount of bound
DNA (PazPaaX complex) to 50%, PA did not affect the PaaX-
DNA binding (Fig. 2), even when this compound was added up
to a final concentration of 2.5 mM (data not shown). A close
analogue of PA-CoA such as benzoyl-CoA had no effect on
PaaX-DNA binding when added to the gel retardation assay up
to a final concentration of 2.5 mM (data not shown). Other CoA
derivatives such as acetyl-CoA and free CoA were also unable
to abolish binding of PaaX to the Pa promoter (data not shown),
thus confirming PA-CoA as the specific inducer molecule of the
paa catabolic genes.
Identification of the PaaX Binding Regions—To localize the
PaaX binding region within the Pa and Pz promoters, DNase I
footprinting experiments were performed using the same tar-
get DNA fragments as those used in the gel retardation assays
reported above. As shown in Fig. 3, an extended binding region
was detected in each promoter. The footprinting assay with the
non-coding strand of the Pa fragment (Fig. 3B) revealed a
protected region, operator region A (ORA), between positions
21 and 151 with respect to the major transcription start site of
paaA that partially overlaps the ribosome-binding site of the
gene (Fig. 4). On the other hand, the non-coding strand of the
Pz fragment was protected by PaaX from DNase I digestion
between positions 230 and 117, operator region Z (ORZ), span-
ning the potential 210 box of the promoter (Figs. 3C and 4).
Similar patterns of DNase I digestion for each of the coding
strands were observed (Fig. 3, A and D). The DNase I-hyper-
sensitive sites observed in ORA and ORZ were spaced at ap-
proximately 10 nucleotide intervals, corresponding to about
one helix turn (Figs. 3 and 4), which suggests binding of PaaX
to one side of the double helix.
FIG. 1. Gel retardation analyses of PaaX binding to the paaZ-
paaA promoter region. The probe DNAs used (Pz-Pa, Pa, and Pz) are
shown schematically on the right, with the Pa and Pz promoters
marked with open arrowheads and the first 44 and 23 amino acids from
the paaA and paaZ gene products represented by striped and black
blocks, respectively. Cell extract and gel retardation analyses were
performed as described under “Experimental Procedures.” Lanes 2–5,
contained 0.3, 1.0, 2.0, and 4.0 mg of total protein of PaaX1 extracts
obtained from cells bearing plasmid pAFX (paaX), respectively. Lanes 1
and 6 contained no extract and 4.0 mg of total protein of PaaX2 extracts
obtained from cells bearing control plasmid pUC18, respectively. The
DNAzPaaX complexes are indicated.
TABLE II
Regulation of expression from the Pz promoter by PaaX
E. coli AF15PZ (Pz-lacZ) cells containing different plasmids were grown in glycerol-containing minimal medium in the absence (uninduced) or
in the presence (induced) of 1 mM PA, until the cultures reached an A600 of 1.0. b-Galactosidase activities were measured with permeabilized cells
as described under “Experimental Procedures.” Results of one experiment are shown; values were reproducible in three separate experiments.
Plasmid(s) Relevant gene(s)
b-Galactosidase activity (Miller units)
Uninduced Induced (1 mM PA) -Fold induction
pUC19 940 950 1.0
pAFK5 paaK 900 916 1.0
pAFX2 paaX BDa BD
pAFK5/pAFX2 paaK/paaX BD 500 .500
a BD, below detection limits.
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Characterization of a Conserved PaaX Binding Motif—Align-
ment of the PaaX binding sequences identified by DNase I
footprinting analyses revealed that each of the operator re-
gions, ORA in promoter Pa and ORZ in promoter Pz, contained
a conserved 15-bp imperfect palindromic motif (Fig. 4).
Whereas the conserved motif in ORA, AATGTGATTCGTGTT,
is located between positions 13 and 117, that of ORZ, TTTAT-
GATTCGCGAT, is located between positions 230 and 216 of
the non-coding strands (Fig. 4). A consensus palindromic se-
quence was deduced to be WWTRTGATTCGYGWT (R is A or G;
W is A or T; and Y is C or T), with its pseudo-dyad axis through
the central T base (underlined) which defines a left-half (LH)
and a right-half (RH) (in italics) region. Since sequences with
dyad symmetry within the operator regions are usually the
binding sites of bacterial transcriptional regulators (21), we
predicted that the described conserved motifs might be the
binding sites of PaaX within ORA and ORZ.
To check the involvement of the conserved motif in the rec-
ognition and binding of PaaX to ORA, base substitutions in the
target motif were generated by recombinant PCR (Fig. 5A), and
the amplified wild-type and mutant Pa fragments were ligated
to the 9lacZ gene of the promoter-probe vector pSJ3 as indi-
cated under “Experimental Procedures.” Since the b-galacto-
sidase levels of permeabilized E. coli AF15 cells expressing the
wild-type Pa-lacZ translational fusion were similar to that of
cells expressing the different mutant Pa-lacZ fusions (Table
III), the possibility that mutations in ORA could negatively
influence the maximum activity of the Pa promoter can be
ruled out. The binding of PaaX to the different promoter frag-
ments was checked in vivo by assaying b-galactosidase activity
in E. coli AF15 cells expressing simultaneously paaX and the
different lacZ translational fusions. As shown in Table III, base
substitutions in the LH region of the conserved motif, i.e. mu-
tant promoters PaM1, PaM5, PaM9, and PaM16 (Fig. 5A),
severely impaired the PaaX-mediated repression of the corre-
sponding lacZ fusions as compared with the wild-type Pa-lacZ
fusion. As expected, the reduction in repression was higher
with mutant promoters PaM1 and PaM9, both containing two
base substitutions, than with mutant promoters PaM5 and
PaM16 bearing only one base substitution (Table III). Interest-
ingly, mutations in the RH region of the conserved motif, i.e.
mutant promoters PaM18, PaM25, and PaM26 (Fig. 5A), did
not cause a reduction in PaaX-mediated repression as high as
that observed with base substitutions in the LH region. Thus,
deletion of the conserved guanine at position 11 of the mutant
promoter PaM18 (Fig. 5A) led to a 3-fold reduction in repres-
sion compared with that observed with the wild-type Pa pro-
moter, and the two base substitutions in mutant promoters
PaM25 and PaM26 (Fig. 5A) maintained the strong repression
effect of PaaX on the corresponding lacZ translational fusions
(Table III).
The effects of the base substitutions on binding of PaaX to
ORA were also tested in vitro by using the wild-type and the
different mutant Pa promoter fragments as probes in gel retar-
dation assays. Whereas mutations in the LH region of the
FIG. 2. Effect of PA and PA-CoA on PaaX-specific binding to its
target DNA. Gel retardation analyses were performed as described
under “Experimental Procedures” using the Pa fragment as probe. 2
and 1 indicate that no extract (lane 1) and 0.2 mg of total protein of
PaaX1 extracts (lanes 2–7) were added to the reaction mixtures, respec-
tively. PA (A) and PA-CoA (B) were added to the reaction mixtures at
the indicated final concentration. Unbound Pa probe and the PazPaaX
complex are shown by arrows.
FIG. 3. DNase I footprinting analyses of the interaction of
PaaX with the paaA and paaZ promoter regions. The DNase I
footprinting experiments were carried out using as probes 59-end-la-
beled non-coding and coding strands of the Pa (274-bp) (A and B) and Pz
(242-bp) (C and D) fragments, as indicated under “Experimental Pro-
cedures.” Lanes 1–4 contained 0, 3, 6, and 15 mg of total protein of
PaaX1 extracts, respectively. Lane 5 contained 15 mg of total protein of
PaaX2 extracts. AG lane corresponds to the A 1 G Maxam and Gilbert
sequencing reaction. Protected regions, ORA and ORZ, are shown in the
autoradiograms by brackets. DNase I-hypersensitive sites are indicated
by arrows.
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conserved motif (mutant promoters PaM1, PaM5, PaM9, and
PaM16) significantly reduced the binding affinity of PaaX to
the mutant promoters as compared with that for the wild-type
Pa promoter, mutations in the RH region (mutant promoters
PaM25 and PaM26) did not (Fig. 5B). The affinity of PaaX for
the mutant promoter PaM18 was lower than that observed for
the other two promoters mutated in the RH region, i.e. PaM25
and PaM26, but higher than that for the promoters mutated in
the LH region (Fig. 5B). These in vitro assays, therefore, are in
agreement with the in vivo results reported above using the
translational lacZ fusions. Taken together, these data suggest
that the conserved motif present in the Pa and Pz promoters is
critical for PaaX repressor binding, with the LH region of the
motif being much more important for repressor binding than
the RH region.
The mutant promoter PaM22, which in addition to a single
base substitution at position 15 harbors the deletion of a nu-
cleotide located six bases downstream of the RH region (Fig.
5A), led to a 6.8-fold reduction in repression (Table III) and to
a significant decrease in PaaX binding affinity (Fig. 5B) as
compared with the wild-type Pa promoter. This suggests that
sequences outside the conserved motif may also influence the
repressor effect of PaaX on the expression of the paa catabolic
genes.
IHF and CRP Behave as Transcriptional Activators of the Pa
and Pz Promoters—Analysis of the paaZ-paaA intergenic re-
gion revealed the existence of two sequences, TATCAACTAC-
TAA and GAGTGCGAAATCTGTCACAGTT, from positions
2125 to 2113 and 273 to 252 relative to the major transcrip-
tion start site of paaA (Fig. 4), that significantly match the
consensus sequences WATCAANNNNTTR (where W is A or T,
R is A or G, and N is any of the four bases) and AANTGT-
FIG. 4. Nucleotide sequence of the paaZ-paaA intergenic region. The translation initiation codon for the paaZ and paaA genes
(represented by arrows) is shown by lowercase type in the corresponding non-coding strands. M and V, is the standard one-letter code abbreviation
for the first amino acid of PaaZ and PaaA, respectively. The ribosome-binding site (RBS) is shown in italics. The transcription start sites in the
Pz and Pa promoters (2) are double-underlined, and the direction of transcription is indicated by bent arrows. The major transcription start site
in Pa is shown in boldface type. The inferred 210 and 235 regions of each promoter are underlined. The PaaX-mediated protection of the coding
and non-coding strands from digestion by DNase I is indicated with boldface letters. The PaaX binding motif is boxed, and its dyad symmetry
indicated by convergent arrows. DNase I-hypersensitive sites in each strand are marked by asterisks. Putative IHF and CRP binding sequences
are shown by brackets. The 59-ends of the PAP and SG-1 primers used to generate the Pa and Pz fragments (see the “Experimental Procedures”),
respectively, are indicated by bent arrows with broken lines.
FIG. 5. Base substitution analyses within the PaaX binding
motif. A, alignment of the sequences of wild-type and different mutant
Pa promoters. The PaaX binding motif is boxed, with its LH and RH (in
italics) regions indicated by convergent arrows. Numbers indicate the
position of the nucleotides within the 15-bp motif. Underlines and
double-underlines indicate the minor and major transcription start
sites, respectively. Base substitutions are shown in lowercase letters.
Asterisks indicate deleted nucleotides. B, binding affinity of PaaX to
wild-type and mutant Pa promoters. Gel retardation assays were per-
formed as described under “Experimental Procedures.” 2 and 1 indi-
cate that no extract (lane 1) and 0.4 mg of total protein of PaaX1 extract
(lanes 2–10) were added to the reaction mixtures, respectively. The
217-bp probe DNAs used were generated as reported under “Experi-
mental Procedures,” and they are as follows: wild-type Pa (lanes 1 and
2), mutant PaM1 (lane 3), mutant PaM5 (lane 4), mutant PaM9 (lane 5),
mutant PaM16 (lane 6), mutant PaM18 (lane 7), mutant PaM22 (lane
8), mutant PaM25 (lane 9), and mutant PaM26 (lane 10). The unbound
probe and the DNAzPaaX complexes are indicated by arrows.
TABLE III
PaaX-mediated repression on different Pa-lacZ reporter fusions
E. coli AF15 cells bearing plasmid pAFPA2, which contains the wild-
type Pa-lacZ fusion, or the different pAFPA2-M plasmids, which con-
tain lacZ fusions to the Pa mutant promoters indicated in Fig. 5A, and
the compatible plasmid pAFX2 (paaX) (1PaaX) or the control plasmid
pCK01 (2PaaX) were grown at 30 °C in glycerol-containing minimal
medium to an A600 of 1.0. b-Galactosidase activities were measured
with permeabilized cells as described under “Experimental Proce-
dures.” Results of one experiment are shown; values were reproducible
in three separate experiments.
Plasmid Relevant genotype
b-Galactosidase activity (Miller units)
2PaaX 1PaaX -Fold repression
pAFPA2 Pa-lacZ 9133 300 30.4
pAFPA2-M1 PaM1-lacZ 9715 8205 1.1
pAFPA2-M5 PaM5-lacZ 9625 2235 4.3
pAFPA2-M9 PaM9-lacZ 8500 4511 1.8
pAFPA2-M16 PaM16-lacZ 10,000 2116 4.7
pAFPA2-M18 PaM18-lacZ 9892 923 10.7
pAFPA2-M22 PaM22-lacZ 10,000 1454 6.8
pAFPA2-M25 PaM25-lacZ 9766 474 20.6
pAFPA2-M26 PaM26-lacZ 9077 449 20.2
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GANNTNNNTCACANTT for binding to the IHF (22) and CRP
(23) global regulators (24), respectively. To determine the pu-
tative role of CRP and IHF in paa regulation, we have used
both genetic and biochemical approaches.
Permeabilized cells of E. coli AFMCPA and AFMCPZ, two E.
coli AFMC derivatives which respectively contain a lacZ trans-
lational fusion with the Pa and Pz promoters stably inserted
into their chromosome, showed b-galactosidase activities of
2300 and 980 Miller units, respectively, when they were grown
in glycerol-containing minimal medium in the presence of PA.
However, when these strains were grown in glucose-containing
minimal medium in the presence of PA, no b-galactosidase
activity was detected, thus suggesting a repression effect on Pa
and Pz by glucose. To determine whether the observed regula-
tion by glucose was mediated by CRP, the Pa-lacZ and Pz-lacZ
fusions were integrated into the chromosome of an isogenic
CRP2 strain, E. coli AFSB, as described under “Experimental
Procedures.” No b-galactosidase activity was detected in the
CRP2 strains AFSBPA (Pa-lacZ) and AFSBPZ (Pz-lacZ) when
the cells were grown in glycerol-containing minimal medium in
the presence of PA. Therefore, both the Pa and Pz promoters
seem to be activated by the cAMP-CRP complex, which ex-
plains their catabolite repression by glucose reported above. To
confirm these genetic experiments, gel retardation assays were
performed with purified CRP in the presence of cAMP and
three different DNA fragments (Pz-Pa, Pz, and Pa) used as
probes. As shown in Fig. 6, whereas a CRP-DNA complex was
observed with the Pz-Pa and the Pa probes, no binding of CRP
to the Pz probe was detected. These results are also in agree-
ment with the observation that a putative CRP-binding site is
located in the paaZ-paaA intergenic region but closer to the Pa
than to the Pz transcriptional start site (Fig. 4).
To study the IHF influence on the expression of the paa
catabolic genes, the Pa-lacZ and Pz-lacZ translational fusions
were stably inserted into the chromosome of isogenic E. coli
S90CRif (himA1himD1), DPB101Rif (himA1himD2), and
DPB102Rif (himA-himD1) strains (himA and himD encode the
two subunits of the IHF heterodimer) as described under “Ex-
perimental Procedures.” The resulting strains were grown in
glycerol-containing minimal medium in the presence of PA, and
the IHF effect on the lacZ expression driven by the Pa and Pz
promoters was checked by b-galactosidase assays. As shown in
Fig. 7A, there was a significant decrease of Pa and Pz promoter
activity in the IHF2 strains DPB101PA (Pa-lacZ), DPB101PZ
(Pz-lacZ), DPB102PA (Pa-lacZ), and DPB102PZ (Pz-lacZ), com-
pared with the promoter activity detected in the IHF1 strains
S90CPA (Pa-lacZ) and S90CPZ (Pz-lacZ). To demonstrate
whether the IHF stimulation observed in vivo from the Pa and
Pz promoters was due to the binding of this regulator to such
promoters, gel retardation assays were carried out. Whereas
purified IHF was able to bind to the Pz-Pa fragment, no binding
to the Pa fragment was detected (Fig. 7B). Moreover, the in-
teraction of IHF with the Pz-Pa intergenic region was specific
since a 100-fold excess of unlabeled Pz-Pa fragment prevented
the formation of the IHF-DNA complex but an excess of unla-
beled Pa fragment did not.
DISCUSSION
In this work, we have used both genetic and biochemical
approaches to study the regulation of the expression of the
divergently transcribed paaZ and paaABCDEFGHIJK cata-
bolic operons responsible for PA catabolism in E. coli. We had
shown previously that the PaaX protein behaves as a transcrip-
tional repressor of the Pa promoter (2). Here, a genetic analysis
based on lacZ translational fusions has shown that PaaX acts
FIG. 6. CRP binding to the paaZ-paaA intergenic region. Gel
retardation analyses were performed as indicated under “Experimental
Procedures” but adding 200 mM cAMP to the reaction mixture and to the
electrophoresis buffer. The probe DNAs used were the Pz (lanes 1 and
2), Pa (lanes 3 and 4), and Pz-Pa (lanes 5 and 6) fragments. 2 and 1,
indicate the absence and presence of 250 nM purified CRP, respectively.
The unbound probe DNAs and the DNA/cAMPzCRP complexes are
indicated by arrows.
FIG. 7. Effect of IHF on expression and binding to the Pa and
Pz promoters. A, IHF effect on Pa and Pz promoter activity in vivo in
isogenic E. coli IHF1 (himA1D1) and IHF2 (himA-D1, himA1D2)
strains. E. coli S90CPA (Pa-lacZ), DPB101PA (Pa-lacZ), DPB102PA
(Pa-lacZ), S90CPZ (Pz-lacZ), DPB101PZ (Pz-lacZ), and DPB102PZ (Pz-
lacZ) cells were grown in glycerol-containing minimal medium in the
presence of 1 mM PA until the cultures reached an A600 of 0.7. Values for
b-galactosidase activity in permeabilized cells are shown (in Miller
units). Results of one experiment are shown, and values were reproduc-
ible in three separate experiments. B, IHF binding to the paaZ-paaA
intergenic region. Gel retardation analyses were performed as indicated
under “Experimental Procedures,” using as probe DNAs the Pz-Pa
(lanes 1–4) and Pa (lanes 5 and 6) fragments. 2 and 1 indicate the
absence and presence of 250 nM purified IHF, respectively. Unlabeled
Pz-Pa and Pa fragments were added at 10 nM to the reaction mixtures
of lanes 3 and 4, respectively. The unbound probe DNAs and the
Pz-PazIHF complex are indicated by arrows.
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also as a repressor of the Pz promoter (Table II). The results of
the gel retardation assays (Fig. 1) indicated that the PaaX
repressor binds specifically and independently to each of the Pa
and Pz promoters, although the binding affinity of PaaX for Pa
was 21-fold higher than that for Pz. DNase I footprinting (Fig.
3) revealed that PaaX protected an extended region of about
50-bp that is located immediately downstream of the transcrip-
tion start sites within the Pa promoter (ORA) and that spans
the 11 and the 210 region in the Pz promoter (ORZ) (Fig. 4).
Although it is likely that the effect of the PaaX protein on the
Pa and Pz promoters will involve different mechanisms of
repression, validation of this assumption requires further
research.
Sequence comparison analysis between ORA and ORZ re-
vealed a 15-bp consensus motif, WWTRTGATTCGYGWT, lo-
cated at the 59-end of the non-coding strands (Fig. 4), which
was shown by point mutation analyses to be indispensable for
binding of PaaX to each promoter. The dyad symmetry of the
PaaX-binding site and the probability that the repressor-DNA
interaction is mediated by a putative helix-turn-helix motif,
amino acid residues 39–64 of PaaX (2), that shares similarity
to that of transcriptional repressors of the GntR family (5, 6)
suggest that the regulator is in an oligomeric form when bound
to DNA. The two sequence repeats of the PaaX binding motif
are related by a (pseudo) dyad axis through the central T base
at position 8 (Fig. 8). Whereas the LH region of the PaaX
binding motif is rather conserved in the operator sequences of
other bacterial regulators such as GntR (6) and PdhR (27)
(which belong to the GntR family) and, surprisingly, CRP (23,
25) and LacI (26) (which belong to the GalR-LacI family), the
RH region differs from that of other operators (Fig. 8). Inter-
estingly, the TGTGA subsequence of the LH region in ORA is
also present in the LH region of the LacI- and CRP-binding
sites (Fig. 8), where it has been shown to play a critical role in
binding to the cognate regulators (25, 28). In this sense, we
have shown here that mutations in the LH region of ORA are
more deleterious for PaaX binding and repression in vivo than
mutations in the RH region, suggesting that the repressor
makes rather different sets of contacts with the two halves of
the binding site and the key interactions are those with the LH
region. Similar non-identical half-site interactions have been
observed also within the lac operator; again the LH region (the
one containing the TGTGA subsequence) is the most critical for
the interactions with the LacI repressor (28). The observed
DNase I-hypersensitive sites in the RH region of ORA and ORZ
could also reflect a more complete protection of the LH regions
by the PaaX repressor, a situation that has been already re-
ported for other operator sequences (28). Although the con-
served PaaX binding motif is essential for PaaX binding, point
mutations outside this motif, such as that of the mutant pro-
moter PaM22, seem to influence the intrinsic affinity of the
repressor for the promoter. Similar data showing that regions
distal to the regulator binding site contribute slightly to the
interactions with the cognate proteins have been previously
reported for other regulators (25, 26, 29).
Since induction of the gene expression driven by the Pa (2)
and Pz (Table II) promoters requires both PA and a functional
PA-CoA ligase, it was reasonable to anticipate that the true
inducer of the paa catabolic cluster was the first intermediate
of the pathway, i.e. PA-CoA, rather than the initial substrate,
i.e. PA. This was confirmed in vitro through gel retardation
assays which revealed that binding of PaaX to the Pa and Pz
promoters is specifically prevented by PA-CoA and not by PA
(Fig. 2), benzoyl-CoA, acetyl-CoA, or free CoA. To date, the E.
coli FadR protein, which controls the expression of many genes
involved in fatty acid synthesis and degradation, was the only
regulator for which there is convincing evidence that interac-
tion of alkyl-CoA compounds with the protein prevents DNA
binding (30). The PaaX repressor constitutes, therefore, the
first example of a regulator protein that responds specifically to
an aryl-CoA compound. It is likely that other regulatory pro-
teins showing a significant amino acid sequence similarity with
PaaX, e.g. the equivalent PaaN repressor (41.4% identity) of
the PA degradation pathway from P. putida U (1), the putative
regulator, ORF13 (31.5% identity), of a predicted PA catabolic
pathway from Bacillus halodurans (GenBankTM accession
number AB011837), and the putative repressor (GenBankTM
accession number AF042490) (24.1% identity) of the 4-chloro-
benzoate dehalogenation pathway involving formation of CoA
derivatives in Arthrobacter sp. TM1 (31), also interact with
aryl-CoA compounds.
In addition to the operon-specific regulation mediated by the
PaaX repressor, the paa catabolic cluster of E. coli is subjected
to control by the two global regulators, CRP (23) and IHF (22).
We have observed that CRP2 E. coli strains failed to express
the Pa-lacZ and Pz-lacZ translational fusions, indicating that
CRP acts as an activator of the gene expression driven by the
Pa and Pz promoters. Gel retardation assays confirmed the
binding of the cAMPzCRP complex to the Pa promoter region
(Fig. 6). Since a potential CRP-binding site was identified at
position 261.5 with respect to the major transcription start site
of Pa (Fig. 4), this promoter might follow a CRP-dependent
activation mechanism similar to that described for class I pro-
moters (32). Although CRP is also necessary for activity of the
Pz promoter, no binding of CRP to the Pz fragment was ob-
served in gel retardation assays (Fig. 6), suggesting that CRP
bound to Pa is able to activate the divergent Pz promoter. Since
the putative CRP-binding site is at position 2138.5 with re-
spect to the transcription start site of Pz and, therefore, too far
upstream to activate directly transcription from this promoter
(33), additional transcription factors may be involved. We have
observed that IHF binds to the paaZ-paaA intergenic region
and stimulates transcription from the Pa and Pz promoters
(Fig. 7). Nucleotide sequence analysis revealed a putative IHF-
binding site within the Pz fragment at position 2115 with
respect to the major transcription start site of Pa (Fig. 4).
Whether IHF-induced bending of the paaZ-paaA intergenic
region can bring together RNA polymerase bound to Pz and
CRP bound to Pa could be an interesting model that remains to
be tested.
Carbon catabolite repression has been extensively described
for the degradation of aromatic compounds in different bacteria
(34). Here we report that when E. coli cells are grown in
FIG. 8. Comparison of the PaaX-binding site with other palin-
dromic operator sequences. Alignment was done with the nucleotide
sequences of the binding sites for the PaaX repressor in Pa (PaaX(Pa))
and Pz (PaaX(Pz)) promoters, the CRP activator in lac promoter (CRP-
(Plac)) (25), the LacI repressor (26), the GntR repressor (6), and the
PdhR repressor (27). The (pseudo) dyad symmetry axis of each sequence
is indicated by a vertical arrow at the top. Nucleotides of the RH region
are shown in italics, and numbers refer to the position of the nucleotides
within the 15-bp PaaX binding motif. Convergent arrows indicate the
LH and RH regions of the PaaX binding motif. The nucleotides identical
to that of PaaX(Pa) are shown in boldface type.
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PA-containing minimal medium in the presence of their pre-
ferred carbon source, i.e. glucose, gene expression from the Pa
and Pz promoters is subject to carbon catabolite repression. In
contrast to the situation in Pseudomonas and other Gram-
negative bacteria where the mechanism of catabolite repres-
sion is not yet understood (34, 35), the effect of glucose in E. coli
is mediated through the action of CRP (23, 25). A similar
repression effect of glucose mediated by the cAMPzCRP com-
plex was also observed in E. coli for the catabolism of other
aromatic compounds such as 2-phenylethylamine (36) and
4-hydroxyphenylacetic acid (14), and it is likely to occur also for
homoprotocatechuic acid degradation (7, 8). Interestingly, the
catabolism of PA in P. putida U is also under catabolic repres-
sion by glucose (1). It is well known that promoters are sub-
jected to various types of physiological controls which adjust
their transcriptional output to the general environmental con-
ditions of the cells (34). We have shown in this work that the
specific PaaX-mediated control of the Pa and Pz promoters for
PA degradation in E. coli is, in turn, subordinated to a super-
imposed regulation mediated by global regulators such as CRP
and IHF, which connect the expression of the paa catabolic
genes to the metabolic and energetic status of the cell.
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